Gapping up
In reaction to earnings/guidance:
- APP +31.5%, SONO +14.9%, ME +9.1%, FORM +8.5%, WMG +8.5%, TPR +7.9%, FLNC +6.8%, MGM +6.4% (also suspends dividend; announces new $2 bln share repurchase program), DIS +6.3% (also announces workforce reduction; to ask Board to reinstate dividend by end of calendar year), AZN +5.7%, WYNN +5.2%, AZEK +5.1%, PYCR +5%, QNST +4.8%, CCJ +4.8%, XPO +4.6%, DHT +4.4%, HOOD +4.4%, TIXT +4.4%, CDAY +4.3%, SLF +4.2%, BRKR +4%, PI +3.9%, MMS +3.2%, ASX +3.1%, HLT +2.9%, HPP +2.8%, CXW +2.5%, CYBR +2.5%, SPGI +2.4%, MPWR +2.2%, ACLS +2.1%, ESE +2%, RE +2%, ITT +2%, ENS +1.9%, ORLY +1.9%, MT +1.8%, PEP +1.8%, WEX +1.8%, APO +1.8%, ESMT +1.8%, ARES +1.7%, TM +1.6%, DUK +1.6%, DBD +1.5%, TWO +1.3%, UL +1.3%, HIMX +1.3%, WTW +1.1%, BWA +1.1%, TU +1.1%, SSTK +0.9%, AB +0.8%, GT +0.8%, PM +0.8%
Other news:
- CSII +47.9% (ABT to acqurie CSII for $20/share)
- NUVA +7% (NuVasive and Globus Medical (GMED) confirm the two parties will combine in all-stock merger)
- CCJ +4.8% (agree on commercial terms to supply Ukraine's full natural UF6)
- MESO +3.8% (FDA grants RMAT designation for rexlemestrocel-L)
- SUMO +2.5% (nearing a $1.7 bln deal to be sold to Francisco Partners according to WSJ)
- SPGI +2.4% (SPGI announces new collaboration agreement with AMZN's AWS)
- POST +2% (POST to acquire select pet food brands from SJM for $1.2 bln in cash and stock)
- CRM +1.9% (Dan Loeb's Third point has stake in CRM according to WSJ)
- MNOV +1.7% (Health Canada grants authorization to commence MN-166 trial in Long COVID)
- ONTF +1.4% (announces new $100 mln capital return program)
- RRC +1.1% (reports proved reserves)
Analyst comments:
- HIMS +6.8% (upgraded to Buy from Hold at Jefferies)